These findings uncovered circLIFR and MSH2 as tumor suppressors involving novel layers of CDDP chemotherapy regulation and provided further evidence that circRNAs are fundamental players in bladder cancer progression. This evidence concerns the gene MSH2 and urinary bladder carcinoma.